Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model. [electronic resource]
Producer: 20200528Description: 121-129 p. digitalISSN:- 1573-6881
- Acetazolamide -- pharmacology
- Animals
- Antigens, Neoplasm -- metabolism
- Carbonic Anhydrase IX -- antagonists & inhibitors
- Carbonic Anhydrase Inhibitors -- pharmacology
- Carcinoma, Hepatocellular -- drug therapy
- Hep G2 Cells
- Hexokinase -- antagonists & inhibitors
- Humans
- Liver Neoplasms, Experimental -- drug therapy
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Pyruvates -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.